<?xml version="1.0" encoding="UTF-8"?>
<XML><RECORDS>
<RECORD>
	<REFERENCE_TYPE>31</REFERENCE_TYPE>
	<AUTHORS>
		<AUTHOR>Liu, Z.</AUTHOR>
		<AUTHOR>Habener, J. F.</AUTHOR>
	</AUTHORS>
	<YEAR>2008</YEAR>
	<TITLE>Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation</TITLE>
	<SECONDARY_TITLE>J Biol Chem</SECONDARY_TITLE>
	<VOLUME>283</VOLUME>
	<NUMBER>13</NUMBER>
	<PAGES>8723-35</PAGES>
	<DATE>Mar 28</DATE>
	<ISBN>0021-9258 (Print)</ISBN>
	<ACCESSION_NUMBER>18216022</ACCESSION_NUMBER>
	<KEYWORDS>
		<KEYWORD>beta Catenin/metabolism</KEYWORD>
		<KEYWORD>Wnt Proteins/*metabolism</KEYWORD>
		<KEYWORD>Venoms/pharmacology</KEYWORD>
		<KEYWORD>TCF Transcription Factors/genetics/*metabolism</KEYWORD>
		<KEYWORD>Signal Transduction/*drug effects</KEYWORD>
		<KEYWORD>Receptors, Glucagon/metabolism</KEYWORD>
		<KEYWORD>Rats</KEYWORD>
		<KEYWORD>Glycogen Synthase Kinase 3/metabolism</KEYWORD>
		<KEYWORD>Glucagon-Like Peptide 1/*pharmacology</KEYWORD>
		<KEYWORD>Frizzled Receptors/metabolism</KEYWORD>
		<KEYWORD>Enzyme Activation</KEYWORD>
		<KEYWORD>Cyclin D1/genetics</KEYWORD>
		<KEYWORD>Cyclic AMP-Dependent Protein Kinases/metabolism</KEYWORD>
		<KEYWORD>Cyclic AMP Response Element-Binding Protein/metabolism</KEYWORD>
		<KEYWORD>Cyclic AMP/metabolism</KEYWORD>
		<KEYWORD>Cell Separation</KEYWORD>
		<KEYWORD>Cell Proliferation/drug effects</KEYWORD>
		<KEYWORD>Cell Line</KEYWORD>
		<KEYWORD>Animals</KEYWORD>
		<KEYWORD>Peptides/pharmacology</KEYWORD>
		<KEYWORD>Mice</KEYWORD>
		<KEYWORD>Ligands</KEYWORD>
		<KEYWORD>Insulin-Secreting Cells/*cytology/drug effects/*metabolism</KEYWORD>
		<KEYWORD>Insulin/pharmacology</KEYWORD>
		<KEYWORD>Humans</KEYWORD>
		<KEYWORD>Receptors</KEYWORD>
		<KEYWORD>Glucagon/metabolism</KEYWORD>
	</KEYWORDS>
	<ABSTRACT>The insulinotropic hormone GLP-1 (glucagon-like peptide-1) is a new therapeutic agent that preserves or restores pancreatic beta cell mass. We report that GLP-1 and its agonist, exendin-4 (Exd4), induce Wnt signaling in pancreatic beta cells, both isolated islets, and in INS-1 cells. Basal and GLP-1 agonist-induced proliferation of beta cells requires active Wnt signaling. Cyclin D1 and c-Myc, determinants of cell proliferation, are up-regulated by Exd4. Basal endogenous Wnt signaling activity depends on Wnt frizzled receptors and the protein kinases Akt and GSK3beta but not cAMP-dependent protein kinase. In contrast, GLP-1 agonists enhance Wnt signaling via GLP-1 receptor-mediated activation of Akt and beta cell independent of GSK3beta. Inhibition of Wnt signaling by small interfering RNAs to beta-catenin or a dominant-negative TCF7L2 decreases both basal and Exd4-induced beta cell proliferation. Wnt signaling appears to mediate GLP-1-induced beta cell proliferation raising possibilities for novel treatments of diabetes.</ABSTRACT>
	<NOTES>DK 30834/DK/NIDDK NIH HHS/United StatesDK 55365/DK/NIDDK NIH HHS/United StatesP30 DK 57521/DK/NIDDK NIH HHS/United StatesJournal ArticleResearch Support, N.I.H., ExtramuralUnited States</NOTES>
	<URL>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18216022</URL>
</RECORD>
</RECORDS></XML>
